Article Text
PDF
Abstract
Purpose To qualitatively and quantitatively characterise the genotypes and phenotypes of Bietti’s crystalline dystrophy (BCD) in a cohort of patients.
Design Cross-sectional and observational study.
Methods Clinically confirmed BCD patients were recruited for genotyping and phenotyping. Multiple retinal imaging modalities were employed. Atrophy in the fovea was adopted as major consideration for staging strategy, while percentage area of autofluorescence (AF) atrophy (PAFA) in the macula was determined for quantitation.
Results In 74 clinically diagnosed BCD patients, c.802–8_810del17insGC was shown the predominant variant of the CYP4V2 gene (allele frequency 55.4%). Sixty-two cases (123 eyes) with full imaging data were classified according to a modified criterion into stages 1 (n=8, 6.50%), 2A (n=9, 7.32%), 2B (n=17, 13.82%), 3A (n=30, 24.39%) and 3B (n=59, 47.97%). The eyes of the stage 2B were particularly deemed ‘high risk’ due to atrophy near fovea, while in stage 3A, though with remarkable foveal atrophy, preserved retinal pigment epithelium/photoreceptor islands near the fovea were found in 14 eyes. A tendency of increase in PAFA with age was found (rs=0.31, p=0.014). Significant PAFA increase was shown through stages 1 to 3B, and best-corrected visual acuity (BCVA, Logarithm of the Minimum Angle of Resolution) was shown to moderately correlate with PAFA (rs=0.56, p<0.001).
Conclusion The PAFA might be an efficient biomarker for BCD severities correlating with BCVA. The highly heterogeneous chorioretinopathy and BCVA of BCD cases appear to be associated with disease stages, progression types and patients’ ages. Foveal involvement should be of a major concern for consideration of potential therapeutic intervention.
- Dystrophy
- Genetics
- Imaging
- Macula
Data availability statement
Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information.
Statistics from Altmetric.com
Footnotes
X @Qian89852330
Contributors QL: proposed the research topic and question. Designed the study and experimental methodology. Collected and analysed data. QL is guarantor. CW: conducted preliminary data analysis. SZ: recruited study participants. Collected demographic data from participants. ZF: provided critical feedback on study design and methodology. Analysed data and interpreted results. XJ: provided critical feedback on study design and methodology. Analysed data and interpreted results. Z-BJ: provided critical feedback on study design and methodology. JFH: proposed the research topic and question. Conceptualised the study framework. Advised on study design and data analysis. X-YP: recruited study participants. Collected demographic data from participants. Conducted preliminary data analysis.
Funding The current study was supported by Beijing Municipal Natural Science Foundation Grant No. 7192039.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Linked Articles
- Highlights from this issue